◀ Back to NFKB1

NFKB1 — NLRP12

Text-mined interactions from Literome

Williams et al., J Biol Chem 2005 (Inflammation) : Monarch-1 reduces NFkappaB activation by TLR signaling molecules MyD88, IRAK-1 ( type I interleukin-1 receptor associated protein kinase ), and TRAF6 ( TNF receptor (TNFR) associated factor ) as well as TNFR signaling molecules TRAF2 and RIP1 but not the downstream NFkappaB subunit p65 ... Reducing Monarch-1 expression with small interference RNA in myeloid/monocytic cells caused a dramatic increase in NFkappaB activation and cytokine expression in response to TLR2/TLR4 agonists, TNFalpha, or M. tuberculosis infection, suggesting that Monarch-1 is a negative regulator of inflammation
Lich et al., J Immunol 2007 (Inflammation) : In this report, we show that Monarch-1 inhibits CD40 mediated activation of NF-kappaB via the non-canonical pathway in human monocytes ... This inhibition stems from the ability of Monarch-1 to associate with and induce proteasome mediated degradation of NF-kappaB inducing kinase
Fontalba et al., J Immunol 2007 : Thus, NLRP2 may control NF-kappaB activation through a regulatory loop